Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An retinitis caused by infection with Histoplasma capsulatum.
No clinical trials have been registered for histoplasmosis retinitis.
4 publications have been identified in PubMed for histoplasmosis retinitis. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (25%), and Epidemiology / Natural History (25%).
Forte P (2026). [PMID: 42103031](https://pubmed.ncbi.nlm.nih.gov/42103031/). *Surv Ophthalmol*. [Review / Meta-Analysis]
Llenas-García J (2025). [PMID: 39821473](https://pubmed.ncbi.nlm.nih.gov/39821473/). *Mycoses*. [Epidemiology / Natural History]
Banz M (2025). [PMID: 41257920](https://pubmed.ncbi.nlm.nih.gov/41257920/). *AIDS research and therapy*. [Case Report / Case Series]
Narula CG (2024). [PMID: 39132106](https://pubmed.ncbi.nlm.nih.gov/39132106/). *Oman journal of ophthalmology*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Oct 3, 2026, 8:11 PM UTC
AI-curated news mentioning histoplasmosis retinitis
Updated Sep 22, 2026
A case study highlights gastric involvement in disseminated histoplasmosis in an immunocompetent patient from a nonendemic region. This finding may expand understanding of histoplasmosis presentations and inform clinical approaches.
A case report highlights secondary hemophagocytic lymphohistiocytosis in an immunocompetent adult, emphasizing the need to differentiate between sarcoidosis and histoplasmosis. This research contributes to the understanding of complex presentations in rare diseases.
A case study highlights the delayed diagnosis of primary cutaneous histoplasmosis in a patient undergoing tumor necrosis factor alpha inhibitor therapy. This underscores the need for heightened awareness of rare infections in immunocompromised patients.